Derma Sciences Inc.

(DSCI) Trade

By |

Profile

Derma Sciences Inc was incorporated on September 10, 1984. The Company is a tissue regeneration company engaged in three segments of the wound care marketplace: pharmaceutical wound care, advanced wound care and traditional wound care products. The Company has one drug candidate that initiated its Phase 3 study. The Company maintains manufacturing facilities in Toronto, Canada and Nantong, China and an established network of third party suppliers for its products. Its products are sold through distributors to health care providers such as wound care centers, extended care facilities, acute care facilities, home health care agencies and physicians' offices. Some of its products are sold through retail channels to care givers. The Company markets its products through direct sales representatives in the United States, Canada and the United Kingdom, and through independent distributors within other select international markets. In Pharmaceutical Wound Care, the DSC127 product is in clinical trial for the treatment of diabetic foot ulcers. The Phase 3 clinical trial for diabetic foot ulcers is expected to be completed by the end of 2015. In addition to the diabetic foot ulcer indication, the Company has begun preclinical testing for scar reduction. The product lines in Advanced Wound Care include MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB, BIOGUARD, and ALGICELL AG. The Traditional Wound Care line consists of gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices. It also manufactures and market adhesive bandages and related first aid products for the medical, industrial, private label and retail markets. It markets a line of wound closure strips, nasal tube fasteners and a variety of catheter fasteners to doctors, clinics, nursing homes, hospitals and other institutions.

Contact Information

Website: www.dermasciences.com
Email: kgolodetz@lhai.com
Main Phone: +1 609 514-4744
Address: 214 Carnegie Center
Address 2: Suite 300
State: NJ
City / Town: Princeton
Country: USA
Postal Code: 08540

Issuer Information

Exchange: NSC
CEO: Stephen T. Wills
Employees: 263
NAICS: Home Health Care Services(621610)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 7.05 52 Wk Low 2.92
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 28,269,225.00 EPS (TTM) -0.40 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Srini Conjeevaram 1,000
Stephen T. Wills 1,000
Samuel E. Navarro 1,000
Amy S. Paul 1,000
Stephen T. Wills 1,000
Bruce F. Wesson 1,000
Edward J. Quilty 1,000
Robert C. Cole 1,000
Robert G. Moussa 1,000
Samuel E. Navarro 1,000
Last 10 Sell Shares
Brett D. Hewlett 1,000
Srini Conjeevaram 1,000
Srini Conjeevaram 1,000
C. Richard Stafford 1,000
C. Richard Stafford 1,000
C. Richard Stafford 1,000
C. Richard Stafford 1,000
C. Richard Stafford 1,000
C. Richard Stafford 1,000
C. Richard Stafford 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 7 7 7 7
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 01/18/17 01/18/17 01/18/17 01/18/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 1 1
Moderate Buy 0 0 0 0
Hold 1 2 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 2 2